The epidermal growth factor receptor (EGFR) family comprehends four different tyrosine
kinases (EGFR, ErbB‐2, ErbB‐3, and ErbB‐4) that are activated following binding to …

Over 90% of all cancers are carcinomas, malignancies derived from cells of epithelial origin.
As carcinomas progress, these tumors may lose epithelial morphology and acquire …

The epidermal growth factor receptor (EGFR) functions in various cellular physiological
processes such as proliferation, differentiation, and motility. Although recent studies have …

S100A7 is a small calcium binding protein, which has been shown to be differentially
expressed in psoriatic skin lesions, as well as in squamous cell tumors of the skin, lung and …

This review summarizes the recent advancements that have improved our understanding of
the functions of prostatic stem/progenitor cells in maintaining homeostasis of the prostate …

Purpose: Most prostate cancer patients develop resistance to androgen deprivation
treatment, resulting in hormone resistance. Epidermal growth factor (EGF) activates several …

Diets high in n-6 fatty acids are associated with an increased risk of bone metastasis from
prostate carces (PCa). The molecular mechanism underlying this phenomenon is largely …

Uwagę zwraca wysoka (zbliżona do 100%) częstość występowania nadmiernej ekspresji
EGFR na komórkach nowotworów okolicy głowy i szyi. Wykazano, iż ekspresja EGFR jest 50 …

Recent advances in basic and clinical oncology have led to the identification and
characterization of several deregulated gene products involved in cancer progression to …

We describe two non-small-cell lung cancer (NSCLC) patients in which treatment with the
epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKIs) gefitinib produced a …